Mini‐Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations

ST Creavin, S Wisniewski… - Cochrane Database …, 2016 - cochranelibrary.com
Background The Mini Mental State Examination (MMSE) is a cognitive test that is commonly
used as part of the evaluation for possible dementia. Objectives To determine the diagnostic …

Reporting of the translation and cultural adaptation procedures of the Addenbrooke's Cognitive Examination version III (ACE-III) and its predecessors: a systematic …

N Mirza, M Panagioti, MW Waheed… - BMC medical research …, 2017 - Springer
Abstract Background The ACE-III, a gold standard for screening cognitive impairment, is
restricted by language and culture, with no uniform set of guidelines for its adaptation. To …

Addenbrooke's cognitive examinations: Ace, ace-r, ace-iii, aceapp, and m-ace

JR Hodges, AJ Larner - Cognitive screening instruments: A practical …, 2017 - Springer
Abstract The Addenbrooke's Cognitive Examination (ACE) was originally developed as a
theoretically motivated extension of the Mini-Mental State Examination (MMSE) which …

Executive function deficits in mild cognitive impairment: evidence from saccade tasks

N Chehrehnegar, M Shati, M Esmaeili… - Aging & mental …, 2022 - Taylor & Francis
Objectives: Early detection of mild cognitive impairment (MCI) is necessary to prevent
irreversible brain damage caused by incipient Alzheimer's disease. It has been showing that …

Behavioral and cognitive markers of mild cognitive impairment: diagnostic value of saccadic eye movements and Simon task

N Chehrehnegar, V Nejati, M Shati, M Esmaeili… - Aging clinical and …, 2019 - Springer
Abstract Background Mild Cognitive Impairment (MCI) has been considered as a prodromal
stage of Alzheimer disease (AD). Subtle changes in specific aspects of executive function …

Comparative analysis of the chemotherapy-related cognitive impairments in patients with breast cancer: a community-based research

M Owrangi, MJ Gholamzadeh… - Cancer …, 2022 - Taylor & Francis
This study aimed to evaluate the effects of two common chemotherapy regimens on breast
cancer (BC) survivors' cognition. The participants comprised 35 patients with BC who …

Novel effects of Rosa damascena extract on patients with neurocognitive disorder and depression: A clinical trial study

E Esfandiary, Z Abdolali, V Omranifard… - … journal of preventive …, 2018 - journals.lww.com
Background: Dementia as a major cognitive neurological disorder is defined as impairment
in one or more cognitive territories compared with the former level of performance. This …

Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and post-stroke dementia: a hospital-based study from northern Iran

S Rezaei, K Asgari Mobarake, A Saberi… - Neurological …, 2016 - Springer
Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is associated with
functional and cognitive outcomes of stroke and plays a key role in preventing neuronal …

[HTML][HTML] Impaired language in Alzheimer's disease: A comparison between English and Persian implicates content-word frequency rather than the noun-verb …

M Sanati, S Bayat, MM Panahi, A Khodadadi… - medRxiv, 2024 - ncbi.nlm.nih.gov
This study challenges the conventional psycholinguistic view that the distinction between
nouns and verbs is pivotal in understanding language impairments in neurological …

Attentional network changes in subjective cognitive decline

M Esmaeili, V Nejati, M Shati, RF Vatan… - Aging Clinical and …, 2021 - Springer
Background Subjective cognitive decline (SCD) is known as the intermediate stage between
normal cognitive aging and mild cognitive impairment (MCI). Although elderly with SCD …